Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Curbing Unproven Stem Cell-Based “Treatments”

Curbing Unproven Stem Cell-Based “Treatments”

FromThe Stem Cell Report with Martin Pera


Curbing Unproven Stem Cell-Based “Treatments”

FromThe Stem Cell Report with Martin Pera

ratings:
Length:
42 minutes
Released:
Jul 9, 2021
Format:
Podcast episode

Description

In this episode, Drs. Zubin Master, Kirstin Matthews, Mohamed Abou-el-Enein, and Sean Morrison join the podcast to talk about unproven stem cell-based interventions. These so-called “stem cell therapies” or “regenerative therapies” currently being marketed direct-to-consumers have insufficient evidence of safety and efficacy to justify their use and pose a potential risk to recipients. A recent paper from Masters, Mathews and Abou-el-Enein published in Stem Cell Reports discusses this global public health problem.GuestsMohamed Abou-El-Enein, MD, PhD, MSPH Keck School of Medicine, University of Southern California, USAZubin Master, PhD, Mayo Clinic, USAKirstin Matthews, PhD, Baker Institute for Public Policy, Rice University, USASean Morrison, PhD, Children’s Research Institute, UT Southwestern, USAHostMartin Pera, PhD – Editor-in-Chief, Stem Cell Reports and The Jackson LaboratoryWebsite: https://www.jax.org/research-and-faculty/faculty/martin-peraTwitter: @martinperaJAXSupporting DocumentsUnproven stem cell interventions: A global public health problem requiring global deliberation About Stem Cell ReportsStem Cell Reports is the Open Access journal of the International Society for Stem Cell Research for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians.About ISSCRWith nearly 4,000 members from more than 65 countries, the International Society for Stem Cell Research is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.Twitter: @ISSCR AcknowledgementsISSCR StaffKeith Alm, Chief Executive OfficerBethany Almon, Senior Manager of Integrated MarketingYvonne Fisher, Managing Editor, Stem Cell ReportsKym Kilbourne, Director of Media and Strategic CommunicationsJack Mosher, Senior Manager of Scientific AffairsVoice WorkJulie PerlinMusic@Konovalov
Released:
Jul 9, 2021
Format:
Podcast episode

Titles in the series (28)

Stem cell science has catapulted to the forefront of biomedical research over the last decade, bringing with it the potential to transform human health and the treatment of devastating diseases and disorders. Martin Pera, an internationally recognized stem cell pioneer and the dynamic editor-in-chief of Stem Cell Reports, explores basic discoveries in stem cell research and its application. Dr. Pera goes “beyond the paper,” bringing authors together to draw new insights and explore the questions and creativity that drive new breakthroughs. Stem Cell Reports, published by the International Society for Stem Cell Research (ISSCR), is an open-access, peer reviewed journal that supports the field of stem cell research and regenerative medicine.